The Pomp Podcast

The episode has scattered genuine insights buried in extensive meandering - the Oracle debt-raise-as-market-mud thesis and the semiconductor/Bitcoin correlation are non-obvious, but they're surrounded by enormous amounts of throat-clearing, 'mhm' filler, product plugs, and personal anecdotes about genealogy bots and sleep earbuds that have zero B2B value. Density is low relative to runtime.

“Oracle's raised over $60 billion since that, uh, September last year. People have questioned them. Their debt was the first one to be an issue. Their CDS started widening out, and this is when the mud started.”

“A chart of semiconductors now in Bitcoin has been one for one for the most part. The other point of this, which I brought up in a video this week, is a index of oil. And tenure rates has also been correlated to it.”

A handful of contrarian angles - Eli Lilly as the biggest future AI company, Bitcoin as 'the purest AI trade,' and the labor-vs-capital read on Microsoft's buyout - are mildly interesting but none are developed rigorously or backed with first-principles reasoning. The rest is standard financial commentary recycled from any macro podcast.

“And that's why I always say bitcoin is the purest AI trade.”

“I have believed for the last three years that unfinished IP was incredibly valuable.”

Jordi Visser is a practicing portfolio manager with real positions and skin in the game, which is credible, but he operates primarily as a financial media/YouTube personality rather than a senior operator who has built or scaled a B2B business at meaningful scale. His perspectives are investor-side market commentary, not practitioner-level operational insight.

“I do not spend a ton of time on single companies with inside the space. Um, if I wanted to say, the only software company that I own is Palantir”

“My biggest position was Marvell. Well then it just fell 20%. My biggest position is now Eli Lilly because it went up 10%.”

The Eli Lilly segment is genuinely data-rich with precise revenue figures, beat margins, and segment-level data; the Oracle and macro sections also cite real numbers. However, several figures are back-of-envelope estimates presented as fact, and the AI/crypto sections rely heavily on vague qualitative claims.

“Eli Lilly reported revenue of $24.4 billion, up 39%. The expectation was 22.6 billion...Mounjaro brought in $10 billion which is up 65%. And Zip Bound brought in $5 billion”

“Oracle's raised over $60 billion since that...September last year”

The host occasionally lands a sharp reframe - 'are you worried about the upside volatility being more muted as well?' and the Eli Lilly 'one foot in old world, one foot in new world' synthesis are genuine follow-ups - but he frequently commandeers the conversation with long personal monologues about his own company and products, and Jordi's sprawling responses go almost entirely unchallenged.

“If the volatility on the downside related to a hack like this is so muted, are you worried about the upside volatility in a bull market being more muted as well?”

“Is it fair to say that your thesis on Eli Lilly is one foot in the old world, one foot in the new world?”